News
Brief news reports on Tuberculosis
By
International Union Against Tuberculosis and Lung Disease
Published: Nov. 20, 2013, 8:09 p.m.·
Tags:
None
The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).
Read More →
By
By Virat Singh and Jyoti Shelar
Published: Nov. 20, 2013, 7:51 p.m.·
Tags:
None
After wrong dosage was discovered in Sandoz's tuberculosis drug 4D, packs of its stronger variant have three pills instead of the stated four.
Read More →
By
Bijoyeta Das
Published: Nov. 20, 2013, 7:39 p.m.·
Tags:
None
The days Rafael Hasta coughs up blood, his son Samuel gives him mashed papaya with boiled rice and red tea. Hasta refuses to eat anything else.
Read More →
By
R. Prasad
Published: Nov. 20, 2013, 7:13 p.m.·
Tags:
None
“A child with TB [is] as likely as an adult with TB to have MDR-TB [multi-drug resistant TB],” notes the WHO Global Tuberculosis Report 2013. that was released last month. “It is therefore essential that the identification of MDR-TB in children be strengthened.”
Read More →
By
R. Prasad
Published: Nov. 20, 2013, 7:02 p.m.·
Tags:
None
Prof. H. Simon Schaaf, a clinical researcher from the Department of Paediatrics and Child Health, Faculty of Health Sciences, Desmond Tutu TB Centre, Stellenbosch University, South Africa has worked extensively on childhood TB and multi-drug resistant TB (MDR-TB) in children. Last year he was awarded an A-rating from the National Research Foundation, South Africa. A-rating is the highest award given to scientists by the Foundation. This award was in recognition of his excellence in research in paediatric TB and MDR-TB in children.
Read More →
By
Talha Burki
Published: Nov. 20, 2013, 6:12 p.m.·
Tags:
None
Adequate funding is crucial in the fight against tuberculosis, but progress worldwide is threatened by underinvestment in tuberculosis research and development.
Read More →
By
Maitri Porecha
Published: Nov. 20, 2013, 5:55 p.m.·
Tags:
None
Interview with Dr Mario Raviglione, Director, World Health Organization's Global Tuberculosis Programme since 2003. Dr Raviglione has worked on TB control issues for two decades. In conversation with Maitri Porecha at the 44th Union World Conference of Lung Health in Paris, France, Dr Raviglione talks about challenges India faces in tackling the dreaded Tuberculosis scourge.
Read More →
By
TB Europe Coalition
Published: Nov. 20, 2013, 5:25 p.m.·
Tags:
None
On 13 November, the European Respiratory Society (ERS) organised a lunch debate “Tuberculosis in Europe: Eliminating the modern threat” hosted by Members of European Parliament (MEPs) Maria da Graça Carvalho and Carl Schlyter in the European Parliament. The meeting was a good opportunity to review the situation of the TB epidemic in the region and take stock of the work of the European Institutions in the fight against the disease.
Read More →
By
Aarhus University
Published: Nov. 20, 2013, 5:17 p.m.·
Tags:
None
Bacteria that cause infectious diseases produce a number of cytotoxins, and an international research team has now found the mechanism behind one of these toxins. The new results could make it possible in future to develop new treatment methods to impair the cytotoxic activity and thereby reduce the severity of infectious diseases.
Read More →
By
TuBerculosis Vaccine Initiative (TBVI)
Published: Nov. 20, 2013, 5:06 p.m.·
Tags:
None
In November 2013 the collaborative infrastructure programme ‘European Research Infrastructures for Poverty Related Diseases’ (EURIPRED) will start in order to reinforce the knowledge infrastructure across diseases. The ultimate aim is to speed the development of new tools (vaccines, drugs, microbicides) to combat Tuberculosis, HIV, Malaria, Hepatitis B and Hepatitis C. EURIPRED is co-funded with €8.5M by the European Commission. Scientists from 17 research partners in 10 countries, including TBVI, will collaborate in this new programme.
Read More →
Page 684 of 878 · Total posts: 10
←First
683
684
685
Last→